{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:29:43Z","timestamp":1773869383304,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Transcatheter aortic valve replacement (TAVR) has become a well-established treatment for aortic stenosis, and its use is expanding to other valvular pathologies. Surgical aortic valve replacement remains the standard for patients with severe aortic regurgitation (AR), especially in those without concurrent aortic stenosis. However, in recent years, TAVR has emerged as a potential option for patients with severe native aortic valve regurgitation (NAVR), despite challenges such as the absence of calcification needed for valve anchoring. We conducted a systematic review and meta-analysis to evaluate the clinical outcomes of TAVR in NAVR. Databases including PubMed, Cochrane Library, Scopus, and ClinicalTrials.gov were searched through June 10, 2024. A total of 23 studies comprising 4397 patients were included. All-cause mortality at 30 days post-TAVR was 12%, while device success was achieved in 86% of cases. Rates of myocardial infarction, stroke, and major bleeding were low at 3%, 3%, and 8%, respectively. Acute kidney injury \u2265 stage 2 occurred in 8% of patients, and 6% experienced major vascular complications. Permanent pacemaker implantation was required in 15% of cases. Moderate-to-severe paravalvular leak and postprocedural moderate-to-severe AR were reported in 10% and 9% of patients, respectively, with wide confidence intervals reflecting variability in outcomes. Overall, these findings suggest that TAVR is a reasonable alternative for selected patients with NAVR, in carefully selected high-risk patients with AR, especially those deemed high risk for surgery or when surgery is contraindicated. However, further large-scale studies with extended follow-up are needed to better define patient selection criteria and to validate the long-term efficacy and safety of TAVR in this population.<\/jats:p>","DOI":"10.1097\/crd.0000000000000960","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:00:10Z","timestamp":1748548810000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Transcatheter Aortic Valve Replacement in Pure Severe Native Aortic Valve Regurgitation: A Systematic Review and Meta-analysis"],"prefix":"10.1097","author":[{"given":"Mayank","family":"Jha","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and New Civil Hospital, Surat, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth Pravin","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshilkumar","family":"Maheta","sequence":"additional","affiliation":[{"name":"Department of Public Health, New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madho","family":"Mal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajid","family":"Siddiq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"R1-20250529","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jcin.2016.08.049","article-title":"Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation.","volume":"9","author":"Franzone","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"R3-20250529","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis.","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250529","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000491919","article-title":"Transcatheter aortic valve replacement for pure native aortic valve regurgitation: a systematic review.","volume":"141","author":"Jiang","year":"2018","journal-title":"Cardiology"},{"key":"R5-20250529","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice.","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"R6-20250529","doi-asserted-by":"crossref","first-page":"e16734","DOI":"10.1016\/j.heliyon.2023.e16734","article-title":"Transcatheter versus surgical aortic valve replacement in patients with aortic regurgitation: a propensity-matched analysis.","volume":"9","author":"Zhou","year":"2023","journal-title":"Heliyon"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/01.CIR.99.14.1851","article-title":"Mortality and morbidity of aortic regurgitation in clinical practice.","volume":"99","author":"Dujardin","year":"1999","journal-title":"Circulation"},{"key":"R8-20250529","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jcin.2015.08.015","article-title":"Expanding indications of transcatheter heart valve interventions.","volume":"8","author":"Praz","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R9-20250529","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cjca.2023.11.023","article-title":"TAVR as an alternative to SAVR for pure native aortic regurgitation.","volume":"40","author":"Noble","year":"2023","journal-title":"Can J Cardiol"},{"key":"R10-20250529","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/CIRCULATIONAHA.104.488825","article-title":"Valvular heart disease.","volume":"112","author":"Bekeredjian","year":"2005","journal-title":"Circulation"},{"key":"R11-20250529","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.hlc.2019.04.012","article-title":"Meta-analysis and meta-regression of transcatheter aortic valve implantation for pure native aortic regurgitation.","volume":"29","author":"Takagi","year":"2020","journal-title":"Heart Lung Circ"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ccd.27370","article-title":"The JUPITER registry: one\u2010year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.","volume":"91","author":"Silaschi","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R13-20250529","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R14-20250529","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary.","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R15-20250529","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","article-title":"Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.","volume":"453","author":"Vahl","year":"2024","journal-title":"Lancet"},{"key":"R16-20250529","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12872-023-03329-1","article-title":"Transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation: one-year outcomes of a single-center study.","volume":"23","author":"Zheng","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R17-20250529","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jcin.2023.05.018","article-title":"Transcatheter treatment of native aortic valve regurgitation.","volume":"16","author":"Garc\u00eda","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R18-20250529","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jcin.2023.07.026","article-title":"Transcatheter aortic valve replacement for pure native aortic valve regurgitation.","volume":"16","author":"Poletti","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R19-20250529","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/atm-21-6936","article-title":"Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices.","volume":"10","author":"Yin","year":"2022","journal-title":"Ann Transl Med"},{"key":"R20-20250529","first-page":"E153","article-title":"Transcatheter aortic valve replacement in aortic regurgitation: the U.S. experience.","volume":"98","author":"Arora","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R21-20250529","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ccd.29189","article-title":"Short\u2010term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.","volume":"97","author":"Isogai","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R22-20250529","first-page":"100480","article-title":"Transcatheter treatment of native aortic valve regurgitation: results from an international registry using the transfemoral Acurate neo valve.","volume":"27","author":"Purita","year":"2020","journal-title":"Int J Cardiovasc Heart"},{"key":"R23-20250529","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.amjcard.2018.05.044","article-title":"Usefulness of transcatheter aortic valve implantation for treatment of pure native aortic valve regurgitation.","volume":"122","author":"De Backer","year":"2018","journal-title":"Am J Cardiol"},{"key":"R24-20250529","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jtcvs.2017.12.150","article-title":"Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve.","volume":"156","author":"Liu","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R25-20250529","first-page":"329","article-title":"Transfemoral implantation of the Acurate neo for the treatment of aortic regurgitation.","volume":"30","author":"Toggweiler","year":"2018","journal-title":"J Invasive Cardiol"},{"key":"R26-20250529","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2017.03.004","article-title":"Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses.","volume":"10","author":"Sawaya","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R27-20250529","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","article-title":"Transcatheter aortic valve replacement in pure native aortic valve regurgitation.","volume":"70","author":"Yoon","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R28-20250529","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jtcvs.2017.09.015","article-title":"Transapical transcatheter aortic valve replacement with a novel transcatheter aortic valve replacement system in high-risk patients with severe aortic valve diseases.","volume":"155","author":"Zhu","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R29-20250529","doi-asserted-by":"crossref","first-page":"B48","DOI":"10.1016\/j.jacc.2015.08.151","article-title":"TCT-105 Transcatheter aortic valve implantation using a new second-generation TAVI system: J-ValveTM for high-risk patients with pure aortic regurgitation.","volume":"66","author":"Guo","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R30-20250529","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.jcin.2015.08.022","article-title":"Transfemoral implantation of a fully repositionable and retrievable transcatheter valve for noncalcified pure aortic regurgitation.","volume":"8","author":"Sch\u00f6fer","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-20250529","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jcin.2015.08.021","article-title":"A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-Valve and early outcome.","volume":"8","author":"Wei","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R32-20250529","doi-asserted-by":"crossref","first-page":"B220","DOI":"10.1016\/j.jacc.2014.07.827","article-title":"TCT-755 trancatheter aortic valve implantation in patients with pure severe native aortic regurgitation: results after 3 year of follow-up.","volume":"64","author":"Rossi","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R33-20250529","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/icvts\/ivu155","article-title":"Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.","volume":"19","author":"Schlingloff","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R34-20250529","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jcin.2014.05.014","article-title":"Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.","volume":"7","author":"Seiffert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"R35-20250529","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4244\/EIJV10I6A127","article-title":"Corevalve implantation for severe aortic regurgitation: a multicentre registry.","volume":"10","author":"Testa","year":"2014","journal-title":"EuroIntervention"},{"key":"R36-20250529","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jcin.2014.04.016","article-title":"Transapical transcatheter aortic valve for severe aortic regurgitation.","volume":"7","author":"Wendt","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"R37-20250529","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jacc.2013.01.018","article-title":"Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.","volume":"61","author":"Roy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R38-20250529","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12872-023-03667-0","article-title":"Transcatheter aortic valve implantation versus surgical aortic valve replacement for pure aortic regurgitation: a systematic review and meta-analysis of 33,484 patients.","volume":"24","author":"Elkasaby","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R39-20250529","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.athoracsur.2022.09.016","article-title":"Transcatheter vs surgical aortic valve replacement in pure native aortic regurgitation.","volume":"115","author":"Mentias","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"R40-20250529","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ccd.22093","article-title":"Experimental evaluation of the JenaClip transcatheter aortic valve.","volume":"74","author":"Lauten","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"R41-20250529","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-019-01422-0","article-title":"Transcatheter aortic valve replacement for pure aortic valve regurgitation: \u201con-label\u201d versus \u201coff-label\u201d use of TAVR devices.","volume":"108","author":"Wernly","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"R42-20250529","doi-asserted-by":"crossref","first-page":"101467","DOI":"10.1016\/j.cpcardiol.2022.101467","article-title":"Cardiovascular outcomes of older versus newer generation transcatheter aortic valve replacement recipients: a systematic review & meta-analysis.","volume":"48","author":"Sattar","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R43-20250529","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1002\/ehf2.14832","article-title":"Transcatheter aortic valve replacement for aortic regurgitation: a systematic review and meta\u2010analysis.","volume":"11","author":"Liu","year":"2024","journal-title":"ESC Heart Fail"},{"key":"R44-20250529","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","article-title":"Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.","volume":"403","author":"Vahl","year":"2024","journal-title":"Lancet"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:00:20Z","timestamp":1748548820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000960","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}